FOURKITES
FourKites today announces new additions to its senior leadership team to maximise customer value. Technology industry veteran Sean Fallon returns to FourKites as Chief Strategy Officer to drive strategy and support continued growth. Chief Product Officer Priya Rajagopalan takes on an expanded role that closely aligns customer operations and product development teams to maximise customer value. In addition, Mike DeAngelis (based in Denmark) joins as Head of International Solutions with a focus on ocean, having formerly worked at Maersk, WiseTech Global and project44.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231116700075/en/
FourKites appoints new executives to accelerate customer-driven innovation (Graphic: Business Wire)
FourKites’ 1,200 customers represent some of the largest and most complex supply chains in the world, and the platform touches over 50% of the Fortune 500. As global supply chains continue to grow in complexity, customers’ need for visibility beyond transportation has accelerated, and now requires end-to-end solutions that provide visibility into inventory, yards, warehouses, stores and beyond.
Gartner reflected this challenge in its 2023 Critical Capabilities for Real-Time Transportation Visibility Platforms report, and recognised FourKites as the top-scoring solution for the world’s most complex supply chains, specifically calling out the company’s “modal coverage and extended capabilities.” In addition, FourKites continues to garner accolades for its industry-leading innovation, most recently in FreightWaves’ FreightTech 25, which recognises the most innovative and disruptive companies in the freight technology sector. FourKites is the only visibility provider named to this year’s list — and together with Amazon Freight and J.B. Hunt, it is one of only three companies to appear on every list since 2018.
To support FourKites’ aggressive innovation agenda to provide maximum visibility for its customers, FourKites has expanded the scope of Chief Product Officer Priya Rajagopalan’s role to encompass customer operations, product and R&D. A seasoned business leader with over two decades of experience in product management, marketing and strategy, Rajagopalan has led FourKites’ Product team since 2016. She helped to build FourKites’ culture of customer-driven innovation, as many of FourKites’ platform capabilities have been developed in close collaboration with customers such as Land O’Lakes, Coca-Cola, Kimberly-Clark, Walmart Canada and others.
In addition, FourKites announced the return of Sean Fallon as Chief Strategy Officer to manage operational execution. Fallon is a seasoned technology executive and advisor, with extensive experience in private equity and venture-backed companies. With a focus on advancing enterprise software and SaaS businesses, he has led businesses through strategic liquidity events and M&A, including the sale of BigMachines to Oracle in 2013. Fallon served as President at FourKites from 2017 to 2021.
FourKites has also appointed Mike DeAngelis as Head of Ocean, where he will drive strategy and innovation around FourKites’ ocean solutions. A proven industry leader, DeAngelis served as General Manager and Head of Product Management at Maersk, Senior VP of global carrier strategy at WiseTech Global, and was most recently Senior Director of Growth, Ocean, at project44.
“We are excited to announce these appointments at a time when customers are looking for more opportunities for digitisation than ever before,” said Mathew Elenjickal, FourKites founder and CEO. “These additions bring a tight connection between the voice of the customer and our high-velocity R&D team, which will yield accelerated opportunities for innovation and customer value.”
These appointments come at a time of continued company growth as customers increasingly seek solutions beyond transportation visibility. Over the last year, FourKites has achieved a 28% increase in customers; 37% growth in its carrier network; and nearly 30% growth in shipment volume, across more than 220 countries and territories. The company sets the pace of innovation in the supply chain visibility market — most recently with Inbound Visibility, Appointment Manager, Fin AI (FourKites Intelligence Network) and My Workspace — as FourKites continues to expand its capabilities beyond transportation to provide customers with real-time insights that expedite decision-making throughout their end-to-end supply chain operations.
About FourKites
Leading global supply chain visibility platform FourKites® empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116700075/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
